ILEVRO (Alcon Laboratories, Inc.)


Welcome to the PulseAid listing for the ILEVRO drug offered from Alcon Laboratories, Inc.. This Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Alcon Laboratories, Inc.
NON-PROPRIETARY NAME: nepafenac
SUBSTANCE NAME: NEPAFENAC
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
ROUTE: OPHTHALMIC
DOSAGE FORM: SUSPENSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-12-20
END MARKETING DATE: 0000-00-00


ILEVRO HUMAN PRESCRIPTION DRUG Details:

Item DescriptionILEVRO from Alcon Laboratories, Inc.
LABELER NAME: Alcon Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 3(mg/mL)
START MARKETING DATE: 2012-12-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0065-1750_1f3c665f-405f-6d15-4d14-b60795a47145
PRODUCT NDC: 0065-1750
APPLICATION NUMBER: NDA203491

Other NEPAFENAC Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alcon Laboratories, Inc.NEVANAC
Physicians Total Care, Inc.Nevanac